Showing results (71-80 of 85) with videos related to
Sort By:
Pageof 9
Scientific Data|July 29, 2022
The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: advanced MRI, clinical, genomics, & radiomicsSpyridon Bakas, Chiharu Sako, Hamed Akbari, et al.Nature Medicine|March 14, 2024
Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim resultsStephen J Bagley, Meghan Logun, Joseph A Fraietta, et al.Cell|May 9, 2026
AI-predicted spatial transcriptomics unlocks breast cancer biomarkers from pathologyEldad D Shulman, Emma M Campagnolo, Roshan Lodha, et al.Nature Cancer|January 12, 2024
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trialStephen J Bagley, Zev A Binder, Lamia Lamrani, et al.Nature Biomedical Engineering|October 16, 2023
Fluorescence lifetime of injected indocyanine green as a universal marker of solid tumours in patientsRahul Pal, Thinzar M Lwin, Murali Krishnamoorthy, et al.Acta Neuropathologica|October 22, 2022
Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1Patrick J Cimino, Courtney Ketchum, Rust Turakulov, et al.Nature Medicine|June 1, 2025
Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trialStephen J Bagley, Arati S Desai, Joseph A Fraietta, et al.Nature|January 17, 2025
Brain-wide neuronal circuit connectome of human glioblastomaYusha Sun, Xin Wang, Daniel Y Zhang, et al.Cell|June 15, 2026
The critical role of the endogenous immune compartment after CAR T cell therapy in recurrent GBMNelson F Freeburg, Daniel Chafamo, Gayathri Konanur Gopikrishna, et al.Cell|June 1, 2022
Glioma progression is shaped by genetic evolution and microenvironment interactionsFrederick S Varn, Kevin C Johnson, Jan Martinek, et al.Pageof 9